Завершено
Фаза II
Россия
Placebo; Tolterodine; ONO-8539; ONO-8539; ONO-8539 · Ono Pharmaceutical Co., Ltd.
A Randomised, Multi-Centre, Double-Blind, Placebo and Active-Controlled, 5-Way Parallel Group Study to Investigate the Efficacy, Safety and Tolerability of ONO-8539 in Patients With Overactive Bladder